Document:

<PAGE>

                                                                    Exhibit 4(B)

                  FORM OF AGREEMENT AND PLAN OF REORGANIZATION

         THIS AGREEMENT AND PLAN OF REORGANIZATION (the "Agreement") is made as
of this 11th day of November, 2004, by and between ING Variable Products Trust,
a Massachusetts business trust (the "Trust") with its principal place of
business at 7337 East Doubletree Ranch Road, Scottsdale, Arizona 85258-2034, on
behalf of the ING VP MidCap Opportunities (the "Acquiring Portfolio"), a
separate series of the Trust, and ING Variable Products Trust, on behalf of the
ING VP Growth Opportunities Portfolio (the "Acquired Portfolio"), another
separate series of the Trust.

         This Agreement is intended to be and is adopted as a plan of
reorganization and liquidation within the meaning of Section 368(a)(1) of the
United States Internal Revenue Code of 1986, as amended (the "Code"). The
reorganization (the "Reorganization") will consist of the transfer of all of the
assets of the Acquired Portfolio to the Acquiring Portfolio in exchange solely
for Class R and Class S voting shares of beneficial interest of the Acquiring
Portfolio (the "Acquiring Portfolio Shares"), the assumption by the Acquiring
Portfolio of all liabilities of the Acquired Portfolio, and the distribution of
the Acquiring Portfolio Shares to the shareholders of the Acquired Portfolio in
complete liquidation of the Acquired Portfolio as provided herein, all upon the
terms and conditions hereinafter set forth in this Agreement.

         WHEREAS, the Acquired Portfolio and the Acquiring Portfolio are series
of an open-end, registered investment company of the management type, and the
Acquired Portfolio owns securities which generally are assets of the character
in which the Acquiring Portfolio is permitted to invest; and

         WHEREAS, the Trustees of the Trust have determined that the exchange of
all of the assets of the Acquired Portfolio for Acquiring Portfolio Shares and
the assumption of all liabilities of the Acquired Portfolio by the Acquiring
Portfolio is in the best interests of the Acquiring Portfolio and its
shareholders and that the interests of the existing shareholders of the
Acquiring Portfolio would not be diluted as a result of this transaction; and

         WHEREAS, the Trustees of the Trust have determined that the exchange of
all of the assets of the Acquired Portfolio for Acquiring Portfolio Shares and
the assumption of all liabilities of the Acquired Portfolio by the Acquiring
Portfolio is in the best interests of the Acquired Portfolio and its
shareholders and that the interests of the existing shareholders of the Acquired
Portfolio would not be diluted as a result of this transaction;

         NOW, THEREFORE, in consideration of the premises and of the covenants
and agreements hereinafter set forth, the parties hereto covenant and agree as
follows:

1.       TRANSFER OF ASSETS OF THE ACQUIRED PORTFOLIO TO THE ACQUIRING PORTFOLIO
         IN EXCHANGE FOR THE ACQUIRING PORTFOLIO SHARES, THE ASSUMPTION OF ALL
         ACQUIRED PORTFOLIO LIABILITIES AND THE LIQUIDATION OF THE ACQUIRED
         PORTFOLIO

         1.1. Subject to the requisite approval of the Acquired Portfolio
shareholders and the other terms and conditions herein set forth and on the
basis of the representations and warranties contained herein, the Acquired
Portfolio agrees to transfer all of the Acquired Portfolio's assets, as set
forth in paragraph 1.2, to the Acquiring Portfolio, and the Acquiring Portfolio
agrees in exchange therefor: (i) to deliver to the Acquired Portfolio the number
of full and fractional Class R and Class S Acquiring Portfolio Shares determined
by dividing the value of the Acquired Portfolio's net assets with respect to
Class R and Class S, computed in the manner and as of the time and date set
forth in paragraph 2.1, by the net asset value of one Acquiring Portfolio Share
of Class R and Class S, computed in the manner and as of the time and date set
forth in paragraph 2.2; and (ii) to assume all liabilities of the
<PAGE>
Acquired Portfolio as set forth in paragraph 1.3. Such transactions shall take
place at the closing provided for in paragraph 3.1 (the "Closing").

         1.2. The assets of the Acquired Portfolio to be acquired by the
Acquiring Portfolio shall consist of all assets and property, including, without
limitation, all cash, securities, commodities and futures interests and
dividends or interests receivable, that are owned by the Acquired Portfolio, and
any deferred or prepaid expenses shown as an asset on the books of the Acquired
Portfolio, on the closing date provided for in paragraph 3.1 (the "Closing
Date") (collectively, "Assets").

         1.3. The Acquired Portfolio will endeavor to discharge all of its known
liabilities and obligations prior to the Closing Date. The Acquiring Portfolio
shall also assume all of the liabilities of the Acquired Portfolio, whether
accrued or contingent, known or unknown, existing at the Valuation Date, as
defined in paragraph 2.1 (collectively, "Liabilities"). On or as soon as
practicable prior to the Closing Date, the Acquired Portfolio will declare and
pay to its shareholders of record one or more dividends and/or other
distributions so that it will have distributed substantially all (and in no
event less than 98%) of its investment company taxable income (computed without
regard to any deduction for dividends paid) and realized net capital gain, if
any, for the current taxable year through the Closing Date.

         1.4. Immediately after the transfer of Assets provided for in paragraph
1.1, the Acquired Portfolio will distribute to the Acquired Portfolio's
shareholders of record, determined as of immediately after the close of business
on the Closing Date (the "Acquired Portfolio Shareholders"), on a pro rata
basis, the Acquiring Portfolio Shares of the same class received by the Acquired
Portfolio pursuant to paragraph 1.1, and will completely liquidate. Such
distribution and liquidation will be accomplished, with respect to the Acquired
Portfolio's shares, by the transfer of the Acquiring Portfolio Shares then
credited to the account of the Acquired Portfolio on the books of the Acquiring
Portfolio to open accounts on the share records of the Acquiring Portfolio in
the names of the Acquired Portfolio Shareholders. The aggregate net asset value
of Class R and Class S Acquiring Portfolio Shares to be so credited to Class R
and Class S Acquired Portfolio Shareholders shall be equal to the aggregate net
asset value of the Acquired Portfolio shares of that same class owned by such
shareholders on the Closing Date. All issued and outstanding shares of the
Acquired Portfolio will simultaneously be canceled on the books of the Acquired
Portfolio.

         1.5. Ownership of Acquiring Portfolio Shares will be shown on the books
of the Acquiring Portfolio's transfer agent, as defined in paragraph 3.3.

         1.6. Any reporting responsibility of the Acquired Portfolio including,
but not limited to, the responsibility for filing of regulatory reports, tax
returns, or other documents with the U.S. Securities and Exchange Commission
(the "Commission"), any state securities commission, and any federal, state or
local tax authorities or any other relevant regulatory authority, is and shall
remain the responsibility of the Acquired Portfolio.

2.       VALUATION

         2.1. The value of the Assets shall be the value computed as of
immediately after the close of business of the New York Stock Exchange ("NYSE")
and after the declaration of any dividends on the Closing Date (such time and
date being hereinafter called the "Valuation Date"), using the valuation
procedures in the then-current prospectus and statement of additional
information with respect to the Acquiring Portfolio, and valuation procedures
established by the Acquiring Portfolio's Board of Trustees.

         2.2. The net asset value of a Class R and Class S Acquiring Portfolio
Share shall be the net asset value per share computed with respect to that class
as of the Valuation Date, using the valuation procedures set forth in the
Acquiring Portfolio's then-current prospectus and statement of additional
information and valuation procedures established by the Acquiring Portfolio's
Board of Trustees.
<PAGE>
         2.3. The number of the Class R and Class S Acquiring Portfolio Shares
to be issued (including fractional shares, if any) in exchange for the Acquired
Portfolio's Assets shall be determined by dividing the value of the net assets
with respect to the Class S shares of the Acquired Portfolio, determined using
the same valuation procedures referred to in paragraph 2.1, by the net asset
value of an Acquiring Portfolio Share, determined in accordance with paragraph
2.2.

         2.4. All computations of value shall be made by the Acquired
Portfolio's designated record keeping agent and shall be subject to review by
the Acquiring Portfolio's record keeping agent and by each Portfolio's
respective independent accountants.

3.       CLOSING AND CLOSING DATE

         3.1. The Closing Date shall be April 17, 2004, or such other date as
the parties may agree to in writing. All acts taking place at the Closing shall
be deemed to take place simultaneously as of immediately after the close of
business on the Closing Date unless otherwise agreed to by the parties. The
close of business on the Closing Date shall be as of 4:00 p.m., Eastern Time.
The Closing shall be held at the offices of the Acquiring Portfolio or at such
other time and/or place as the parties may agree.

         3.2. The Acquired Portfolio shall direct State Street Bank and Trust
Company, as custodian for the Acquired Portfolio (the "Custodian"), to deliver,
at the Closing, a certificate of an authorized officer stating that (i) the
Assets shall have been delivered in proper form to the Acquiring Portfolio
within two business days prior to or on the Closing Date, and (ii) all necessary
taxes in connection with the delivery of the Assets, including all applicable
federal and state stock transfer stamps, if any, have been paid or provision for
payment has been made. The Acquired Portfolio's portfolio securities represented
by a certificate or other written instrument shall be presented by the Acquired
Portfolio Custodian to the custodian for the Acquiring Portfolio for examination
no later than five business days preceding the Closing Date, and shall be
transferred and delivered by the Acquired Portfolio as of the Closing Date for
the account of the Acquiring Portfolio duly endorsed in proper form for transfer
in such condition as to constitute good delivery thereof. The Custodian shall
deliver, as of the Closing Date by Date by book entry, in accordance with the
customary practices of the Custodian and any securities depository (as defined
in Rule 17f-4 under the Investment Company Act of 1940, as amended (the "1940
Act")) in which the Acquired Portfolio's Assets are deposited, the Assets that
are deposited with such depositories. The cash to be transferred by the Acquired
Portfolio shall be delivered by wire transfer of federal funds on the Closing
Date.

         3.3. The Acquired Portfolio shall direct DST Systems, Inc. (the
"Transfer Agent"), on behalf of the Acquired Portfolio, to deliver at the
Closing a certificate of an authorized officer stating that its records contain
the names and addresses of the Acquired Portfolio Shareholders and the number
and percentage ownership of outstanding Class R and Class S shares owned by each
such shareholder immediately prior to the Closing. The Acquiring Portfolio shall
issue and deliver a confirmation evidencing the Acquiring Portfolio Shares to be
credited on the Closing Date to the Secretary of the Acquiring Portfolio, or
provide evidence satisfactory to the Acquired Portfolio that such Acquiring
Portfolio Shares have been credited to the Acquired Portfolio's account on the
books of the Acquiring Portfolio. At the Closing each party shall deliver to the
other such bills of sale, checks, assignments, share certificates, if any,
receipts or other documents as such other party or its counsel may reasonably
request.

         3.4. In the event that on the Valuation Date (a) the NYSE or another
primary trading market for portfolio securities of the Acquiring Portfolio or
the Acquired Portfolio shall be closed to trading or trading thereupon shall be
restricted, or (b) trading or the reporting of trading on such Exchange or
elsewhere shall be disrupted so that, in the judgment of the Board of Trustees,
respectively, accurate appraisal of the value of the net assets of the Acquiring
Portfolio or the Acquired Portfolio, respectively, is impracticable, the Closing
Date shall be postponed until the first business day after the day when trading
shall have been fully resumed and reporting shall have been restored.

4.       REPRESENTATIONS AND WARRANTIES
<PAGE>
         4.1. The Trust on behalf of the Acquired Portfolio, represents and
warrants as follows:

         (a) The Acquired Portfolio is duly organized as a series of the Trust
which is a business trust duly organized, validly existing and in good standing
under the laws of the Commonwealth of Massachusetts with power under the Trust's
Declaration of Trust ("Declaration of Trust") to own all of its Assets and to
carry on its business as it is now being conducted;

         (b) The Trust is a registered investment company classified as a
management company of the open-end type, and its registration with the
Commission as an investment company under the 1940 Act, and the registration of
shares of the Acquired Portfolio under the Securities Act of 1933, as amended
("1933 Act"), is in full force and effect;

         (c) No consent, approval, authorization, or order of any court or
governmental authority is required for the consummation by the Acquired
Portfolio of the transactions contemplated herein, except such as have been
obtained under the 1933 Act, the Securities Exchange Act of 1934, as amended
(the "1934 Act") and the 1940 Act and such as may be required by state
securities laws;

         (d) The current prospectus and statement of additional information of
the Acquired Portfolio and each prospectus and statement of additional
information of the Acquired Portfolio used during the three years previous to
the date of this Agreement conforms or conformed at the time of its use in all
material respects to the applicable requirements of the 1933 Act and the 1940
Act and the rules and regulations of the Commission thereunder and does not or
did not at the time of its use include any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were
made, not materially misleading;

         (e) On the Closing Date, the Trust, on behalf of the Acquired Portfolio
will have good and marketable title to the Assets and full right, power, and
authority to sell, assign, transfer and deliver such Assets hereunder free of
any liens or other encumbrances, and upon delivery and payment for such Assets,
the Trust, on behalf of the Acquiring Portfolio will acquire good and marketable
title thereto, subject to no restrictions on the full transfer thereof,
including such restrictions as might arise under the 1933 Act, other than as
disclosed to the Acquiring Portfolio;

         (f) The Acquired Portfolio is not engaged currently, and the execution,
delivery and performance of this Agreement will not result, in (i) a material
violation of the Trust's Declaration of Trust or By-Laws or of any agreement,
indenture, instrument, contract, lease or other undertaking to which the Trust
on behalf of the Acquired Portfolio, is a party or by which it is bound, or (ii)
the acceleration of any obligation, or the imposition of any penalty, under any
agreement, indenture, instrument, contract, lease, judgment or decree to which
the Trust, on behalf of the Acquired Portfolio is a party or by which it is
bound;

         (g) All material contracts or other commitments of the Acquired
Portfolio (other than this Agreement and certain investment contracts, including
options, futures, and forward contracts) will terminate without liability to the
Acquired Portfolio on or prior to the Closing Date;

         (h) Except as otherwise disclosed in writing to and accepted by the
Trust, on behalf of the Acquiring Portfolio, no litigation or administrative
proceeding or investigation of or before any court or governmental body is
presently pending or, to its knowledge, threatened against the Acquired
Portfolio, or any of its properties or assets that, if adversely determined,
would materially and adversely affect the Acquired Portfolio's financial
condition or the conduct of its business. The Trust, on behalf of the Acquired
Portfolio, knows of no facts which might form the basis for the institution of
such proceedings and is not a party to or subject to the provisions of any
order, decree or judgment of any court or governmental body which materially and
adversely affects the Acquired Portfolio's business or the Acquired Portfolio's
ability to consummate the transactions herein contemplated;
<PAGE>
         (i) The Statement of Assets and Liabilities, Statements of Operations
and Changes in Net Assets, and Portfolio of Investments of the Acquired
Portfolio as of December 31, 2002 have been audited by KPMG LLP, independent
auditors, and are in accordance with generally accepted accounting principles in
the United States ("GAAP") consistently applied, and such statements (copies of
which have been furnished to the Acquiring Portfolio) present fairly, in all
material respects, the financial condition of the Acquired Portfolio as of such
date in accordance with GAAP, and there are no known contingent liabilities of
the Acquired Portfolio required to be reflected on a balance sheet (including
the notes thereto) in accordance with GAAP as of such date not disclosed
therein;

         (j) Since December 31, 2002, there has not been any material adverse
change in the Acquired Portfolio's financial condition, assets, liabilities or
business, other than changes occurring in the ordinary course of business, or
any incurrence by the Acquired Portfolio of indebtedness maturing more than one
year from the date such indebtedness was incurred, except as otherwise disclosed
to and accepted by the Acquiring Portfolio. For the purposes of this
subparagraph (j), a decline in net asset value per share of the Acquired
Portfolio due to declines in market values of securities in the Acquired
Portfolio's portfolio, the discharge of Acquired Portfolio liabilities, or the
redemption of Acquired Portfolio Shares by shareholders of the Acquired
Portfolio shall not constitute a material adverse change;

         (k) On the Closing Date, all Federal and other tax returns, dividend
reporting forms, and other tax-related reports of the Acquired Portfolio
required by law to have been filed by such date (including any extensions) shall
have been filed and are or will be correct in all material respects, and all
Federal and other taxes shown as due or required to be shown as due on said
returns and reports shall have been paid or provision shall have been made for
the payment thereof, and to the best of the Acquired Portfolio's knowledge, no
such return is currently under audit and no assessment has been asserted with
respect to such returns;

         (l) For each taxable year of its operation (including the taxable year
ending on the Closing Date), the Acquired Portfolio has met (or will meet) the
requirements of Subchapter M of the Code for qualification as a regulated
investment company, has complied (or will comply) with the applicable
diversification requirements imposed by Subchapter L of the Code, has been (or
will be) eligible to and has computed (or will compute) its federal income tax
under Section 852 of the Code, and will have distributed all of its investment
company taxable income and net capital gain (as defined in the Code) that has
accrued through the Closing Date, and before the Closing Date will have declared
dividends sufficient to distribute all of its investment company taxable income
and net capital gain for the period ending on the Closing Date;

         (m) All issued and outstanding shares of the Acquired Portfolio are,
and on the Closing Date will be, duly and validly issued and outstanding, fully
paid and non-assessable by the Trust and have been offered and sold in every
state and the District of Columbia in compliance in all material respects with
applicable registration requirements of the 1933 Act and state securities laws.
All of the issued and outstanding shares of the Acquired Portfolio will, at the
time of Closing, be held by the persons and in the amounts set forth in the
records of the Transfer Agent, on behalf of the Acquired Portfolio, as provided
in paragraph 3.3. The Acquired Portfolio does not have outstanding any options,
warrants or other rights to subscribe for or purchase any of the shares of the
Acquired Portfolio, nor is there outstanding any security convertible into any
of the Acquired Portfolio shares;

         (n) The execution, delivery and performance of this Agreement will have
been duly authorized prior to the Closing Date by all necessary action, if any,
on the part of the Trustees of the Trust on behalf of the Acquired Portfolio,
and, subject to the approval of the shareholders of the Acquired Portfolio, this
Agreement will constitute a valid and binding obligation of the Acquired
Portfolio, enforceable in accordance with its terms, subject, as to enforcement,
to bankruptcy, insolvency, reorganization, moratorium and other laws relating to
or affecting creditors' rights and to general equity principles;

         (o) The information to be furnished by the Acquired Portfolio for use
in registration statements, proxy materials and other documents filed or to be
filed with any federal, state or local regulatory authority (including the
<PAGE>
National Association of Securities Dealers, Inc.), which may be necessary in
connection with the transactions contemplated hereby, shall be accurate and
complete in all material respects and shall comply in all material respects with
Federal securities and other laws and regulations thereunder applicable thereto;
and

         (p) The proxy statement of the Acquired Portfolio (the "Proxy
Statement") to be included in the Registration Statement, insofar as it relates
to the Acquired Portfolio, will, on the effective date of the Registration
Statement and on the Closing Date (i) not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under
which such statements were made, not materially misleading provided, however,
that the representations and warranties in this subparagraph (p) shall not apply
to statements in or omissions from the Proxy Statement and the Registration
Statement made in reliance upon and in conformity with information that was
furnished by the Acquiring Portfolio for use therein, and (ii) comply in all
material respects with the provisions of the 1933 Act, the 1934 Act and the 1940
Act and the rules and regulations thereunder.

         4.2. The Trust, on behalf of the Acquiring Portfolio, represents and
warrants as follows:

         (a) The Acquiring Portfolio is duly organized as a series of the Trust,
which is a business trust duly organized, validly existing and in good standing
under the laws of the Commonwealth of Massachusetts with power under the Trust's
Declaration of Trust to own all of its properties and assets and to carry on its
business as it is now being conducted;

         (b) The Trust is a registered investment company classified as a
management company of the open-end type, and its registration with the
Commission as an investment company under the 1940 Act and the registration of
shares of the Acquiring Portfolio under the 1933 Act, is in full force and
effect;

         (c) No consent, approval, authorization, or order of any court or
governmental authority is required for the consummation by the Acquiring
Portfolio of the transactions contemplated herein, except such as have been
obtained under the 1933 Act, the 1934 Act and the 1940 Act and such as may be
required by state securities laws;

         (d) The current prospectus and statement of additional information of
the Acquiring Portfolio and each prospectus and statement of additional
information of the Acquiring Portfolio used during the three years previous to
the date of this Agreement conforms or conformed at the time of its use in all
material respects to the applicable requirements of the 1933 Act and the 1940
Act and the rules and regulations of the Commission thereunder and does not or
did not at the time of its use include any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were
made, not materially misleading;

         (e) On the Closing Date, the Acquiring Portfolio will have good and
marketable title to the Acquiring Portfolio's assets, free of any liens of other
encumbrances, except those liens or encumbrances as to which the Acquired
Portfolio has received notice and necessary documentation at or prior to the
Closing;

         (f) The Acquiring Portfolio is not engaged currently, and the
execution, delivery and performance of this Agreement will not result, in (i) a
material violation of the Trust's Declaration of Trust or By-Laws or of any
agreement, indenture, instrument, contract, lease or other undertaking to which
the Trust, on behalf of the Acquiring Portfolio, is a party or by which it is
bound, or (ii) the acceleration of any obligation, or the imposition of any
penalty, under any agreement, indenture, instrument, contract, lease, judgment
or decree to which the Trust on behalf of the Acquiring Portfolio, is a party or
by which it is bound;

         (g) Except as otherwise disclosed in writing to and accepted by the
Trust, on behalf of the Acquired Portfolio, no litigation or administrative
proceeding or investigation of or before any court or governmental body is
presently pending or, to its knowledge, threatened against the Trust, on behalf
of the Acquiring Portfolio, or any of the Acquiring Portfolio's properties or
assets that, if adversely determined, would materially and adversely affect the
<PAGE>
Acquiring Portfolio's financial condition or the conduct of its business. The
Trust on behalf of the Acquiring Portfolio knows of no facts which might form
the basis for the institution of such proceedings and is not a party to or
subject to the provisions of any order, decree or judgment of any court or
governmental body which materially and adversely affects the Acquiring
Portfolio's business or the Acquiring Portfolio's ability to consummate the
transactions herein contemplated;

         (h) The Statement of Assets and Liabilities, Statements of Operations
and Changes in Net Assets and Portfolio of Investments of the Acquiring
Portfolio as of December 31, 2002 have been audited by KPMG LLP, independent
auditors, and are in accordance with GAAP consistently applied, and such
statements (copies of which have been furnished to the Acquired Portfolio)
present fairly, in all material respects, the financial condition of the
Acquiring Portfolio as of such date in accordance with GAAP, and there are no
known contingent liabilities of the Acquiring Portfolio required to be reflected
on a balance sheet (including the notes thereto) in accordance with GAAP as of
such date not disclosed therein;

         (i) Since December 31, 2002, there has not been any material adverse
change in the Acquiring Portfolio's financial condition, assets, liabilities or
business, other than changes occurring in the ordinary course of business, or
any incurrence by the Acquiring Portfolio of indebtedness maturing more than one
year from the date such indebtedness was incurred, except as otherwise disclosed
to and accepted by the Acquired Portfolio. For purposes of this subparagraph
(i), a decline in net asset value per share of the Acquiring Portfolio due to
declines in market values of securities in the Acquiring Portfolio's portfolio,
the discharge of Acquiring Portfolio liabilities, or the redemption of Acquiring
Portfolio Shares by shareholders of the Acquiring Portfolio, shall not
constitute a material adverse change;

         (j) On the Closing Date, all Federal and other tax returns, dividend
reporting forms, and other tax-related reports of the Acquiring Portfolio
required by law to have been filed by such date (including any extensions) shall
have been filed and are or will be correct in all material respects, and all
Federal and other taxes shown as due or required to be shown as due on said
returns and reports shall have been paid or provision shall have been made for
the payment thereof, and to the best of the Acquiring Portfolio's knowledge no
such return is currently under audit and no assessment has been asserted with
respect to such returns;

         (k) For each taxable year of its operation (including the taxable year
that includes the Closing Date), the Acquiring Portfolio has met (or will meet)
the requirements of Subchapter M of the Code for qualification as a regulated
investment company, has complied (or will comply) with the applicable
diversification requirements imposed by Subchapter L of the Code, has been
eligible to (or will be eligible to) and has computed (or will compute) its
federal income tax under Section 852 of the Code, and has distributed all of its
investment company taxable income and net capital gain (as defined in the Code)
for periods ending prior to the Closing Date;

         (l) All issued and outstanding Acquiring Portfolio Shares are, and on
the Closing Date will be, duly and validly issued and outstanding, fully paid
and non-assessable (recognizing that, under Massachusetts law, it is
theoretically possible that shareholders of the Acquiring Portfolio could, under
certain circumstances, be held personally liable for obligations of the
Acquiring Portfolio) and have been offered and sold in every state and the
District of Columbia in compliance in all material respects with applicable
registration requirements of the 1933 Act and state securities laws. The
Acquiring Portfolio does not have outstanding any options, warrants or other
rights to subscribe for or purchase any Acquiring Portfolio Shares, nor is there
outstanding any security convertible into any Acquiring Portfolio Shares;

         (m) The execution, delivery and performance of this Agreement will have
been fully authorized prior to the Closing Date by all necessary action, if any,
on the part of the Trustees of the Trust on behalf of the Acquiring Portfolio
and this Agreement will constitute a valid and binding obligation of the Trust,
on behalf of the Acquiring Portfolio, enforceable in accordance with its terms,
subject, as to enforcement, to bankruptcy, insolvency, reorganization,
moratorium and other laws relating to or affecting creditors' rights and to
general equity principles;
<PAGE>
         (n) Acquiring Portfolio Shares to be issued and delivered to the
Acquired Portfolio, for the account of the Acquired Portfolio Shareholders,
pursuant to the terms of this Agreement, will on the Closing Date have been duly
authorized and, when so issued and delivered, will be duly and validly issued
Acquiring Portfolio Shares, and will be fully paid and non-assessable
(recognizing that, under Massachusetts law, it is theoretically possible that
shareholders of the Acquiring Portfolio could, under certain circumstances, be
held personally liable for obligations of the Acquiring Portfolio);

         (o) The information to be furnished by the Trust for use in the
registration statements, proxy materials and other documents that may be
necessary in connection with the transactions contemplated hereby shall be
accurate and complete in all material respects and shall comply in all material
respects with Federal securities and other laws and regulations applicable
thereto; and

         (p) That insofar as it relates to the Acquiring Portfolio, the
Registration Statement relating to the Acquiring Portfolio Shares issuable
hereunder, and the proxy materials of the Acquired Portfolio to be included in
the Registration Statement, and any amendment or supplement to the foregoing,
will, from the effective date of the Registration Statement through the date of
the meeting of shareholders of the Acquired Portfolio contemplated therein (i)
not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which such statements were made, not
misleading provided, however, that the representations and warranties in this
subparagraph (p) shall not apply to statements in or omissions from the
Registration Statement made in reliance upon and in conformity with information
that was furnished by the Acquired Portfolio for use therein, and (ii) comply in
all material respects with the provisions of the 1933 Act, the 1934 Act and the
1940 Act and the rules and regulations thereunder.

5.       COVENANTS OF THE ACQUIRING PORTFOLIO AND THE ACQUIRED PORTFOLIO

         5.1. The Acquiring Portfolio and the Acquired Portfolio each will
operate its business in the ordinary course between the date hereof and the
Closing Date, it being understood that such ordinary course of business will
include the declaration and payment of customary dividends and distributions,
and any other distribution that may be advisable.

         5.2. The Trust will call a meeting of the shareholders of the Acquired
Portfolio to consider and act upon this Agreement and to take all other action
necessary to obtain approval of the transactions contemplated herein.

         5.3. The Acquired Portfolio covenants that the Class R and Class S
Acquiring Portfolio Shares to be issued hereunder are not being acquired for the
purpose of making any distribution thereof, other than in accordance with the
terms of this Agreement.

         5.4. Subject to the provisions of this Agreement, the Acquiring
Portfolio and the Acquired Portfolio will each take, or cause to be taken, all
action, and do or cause to be done, all things reasonably necessary, proper or
advisable to consummate and make effective the transactions contemplated by this
Agreement.

         5.5. As soon as is reasonably practicable after the Closing, the
Acquired Portfolio will make a liquidating distribution to its shareholders
consisting of the Class R and Class S Acquiring Portfolio Shares received at the
Closing.

         5.6. The Acquiring Portfolio and the Acquired Portfolio shall each use
its reasonable best efforts to fulfill or obtain the fulfillment of the
conditions precedent to effect the transactions contemplated by this Agreement
as promptly as practicable.

         5.7. The Trust, on behalf of the Acquired Portfolio, covenants that the
Trust will, from time to time, as and when reasonably requested by the Acquiring
Portfolio, execute and deliver or cause to be executed and delivered all such
assignments and other instruments, and will take or cause to be taken such
further action as the
<PAGE>
Trust, on behalf of the Acquiring Portfolio, may reasonably deem necessary or
desirable in order to vest in and confirm (a) the Trust's, on behalf of the
Acquired Portfolio's, title to and possession of the Acquiring Portfolio Shares
to be delivered hereunder, and (b) Trust's, on behalf of the Acquiring
Portfolio's, title to and possession of all the assets, and to carry out the
intent and purpose of this Agreement.

         5.8. The Acquiring Portfolio will use all reasonable efforts to obtain
the approvals and authorizations required by the 1933 Act, the 1940 Act and such
of the state blue sky or securities laws as may be necessary in order to
continue its operations after the Closing Date.

6.       CONDITIONS PRECEDENT TO OBLIGATIONS OF THE ACQUIRED PORTFOLIO

         The obligations of the Trust, on behalf of the Acquired Portfolio, to
consummate the transactions provided for herein shall be subject, at the Trust's
election, to the performance by the Trust, on behalf of the Acquiring Portfolio,
of all the obligations to be performed by it hereunder on or before the Closing
Date, and, in addition thereto, the following further conditions:

         6.1. All representations and warranties of the Trust, on behalf of the
Acquiring Portfolio, contained in this Agreement shall be true and correct in
all material respects as of the date hereof and, except as they may be affected
by the transactions contemplated by this Agreement, as of the Closing Date, with
the same force and effect as if made on and as of the Closing Date;

         6.2. The Acquiring Portfolio shall have delivered to the Acquired
Portfolio a certificate executed in its name by its President or Vice President
and its Treasurer or Assistant Treasurer, in a form reasonably satisfactory to
the Acquired Portfolio and dated as of the Closing Date, to the effect that the
representations and warranties of the Acquiring Portfolio made in this Agreement
are true and correct at and as of the Closing Date, except as they may be
affected by the transactions contemplated by this Agreement and as to such other
matters as the Acquired Portfolio shall reasonably request;

         6.3. The Trust, on behalf of the Acquiring Portfolio, shall have
performed all of the covenants and complied with all of the provisions required
by this Agreement to be performed or complied with by the Trust, on behalf of
the Acquiring Portfolio, on or before the Closing Date; and

         6.4. The Acquired Portfolio and the Acquiring Portfolio shall have
agreed on the number of full and fractional Acquiring Portfolio Shares of Class
R and Class S to be issued in connection with the Reorganization after such
number has been calculated in accordance with paragraph 1.1.

7.       CONDITIONS PRECEDENT TO OBLIGATIONS OF THE ACQUIRING PORTFOLIO

         The obligations of the Trust, on behalf of the Acquiring Portfolio, to
complete the transactions provided for herein shall be subject, at the Trust's
election, to the performance by the Trust on behalf of the Acquired Portfolio of
all of the obligations to be performed by it hereunder on or before the Closing
Date and, in addition thereto, the following conditions:

         7.1. All representations and warranties of the Trust, on behalf of the
Acquired Portfolio, contained in this Agreement shall be true and correct in all
material respects as of the date hereof and, except as they may be affected by
the transactions contemplated by this Agreement, as of the Closing Date, with
the same force and effect as if made on and as of the Closing Date;

         7.2. The Trust shall have delivered to the Acquiring Portfolio a
statement of the Acquired Portfolio's assets and liabilities, as of the Closing
Date, certified by the Treasurer of the Trust;
<PAGE>
         7.3 The Acquired Portfolio shall have delivered to the Acquiring
Portfolio a certificate executed in its name by its President or Vice President
and its Treasurer or Assistant Treasurer, in a form reasonably satisfactory to
the Acquiring Portfolio and dated as of the Closing Date, to the effect that the
representations and warranties of the Acquired Portfolio made in this Agreement
are true and correct at and as of the Closing Date, except as they may be
affected by the transactions contemplated by this Agreement and as to such other
matters as the Acquiring Portfolio shall reasonably request;

         7.4. The Trust, on behalf of the Acquired Portfolio, shall have
performed all of the covenants and complied with all of the provisions required
by this Agreement to be performed or complied with by the Trust, on behalf of
the Acquired Portfolio, on or before the Closing Date;

         7.5. The Acquired Portfolio and the Acquiring Portfolio shall have
agreed on the number of full and fractional Acquiring Portfolio Shares of Class
R and Class S to be issued in connection with the Reorganization after such
number has been calculated in accordance with paragraph 1.1; and

         7.6. The Acquired Portfolio shall have declared and paid a distribution
or distributions prior to the Closing that, together with all previous
distributions, shall have the effect of distributing to its shareholders (i) all
of its investment company taxable income and all of its net realized capital
gains, if any, for the period from the close of its last fiscal year to 4:00
p.m. Eastern time on the Closing; and (ii) any undistributed investment company
taxable income and net realized capital gains from any period to the extent not
otherwise already distributed.

8.       FURTHER CONDITIONS PRECEDENT TO OBLIGATIONS OF THE ACQUIRING PORTFOLIO
         AND THE ACQUIRED PORTFOLIO

         If any of the conditions set forth below have not been satisfied on or
before the Closing Date with respect to the Trust, on behalf of the Acquired
Portfolio, or the Trust, on behalf of the Acquiring Portfolio, the other party
to this Agreement shall, at its option, not be required to consummate the
transactions contemplated by this Agreement:

         8.1. The Agreement and the transactions contemplated herein shall have
been approved by the requisite vote of the holders of the outstanding shares of
the Acquired Portfolio in accordance with the provisions of the Trust's
Declaration of Trust, By-Laws, applicable Massachusetts law and the 1940 Act,
and certified copies of the resolutions evidencing such approval shall have been
delivered to the Acquiring Portfolio. Notwithstanding anything herein to the
contrary, the Trust may not waive the conditions set forth in this paragraph 8.1
on behalf of the Acquired Portfolio or the Acquiring Portfolio;

         8.2. On the Closing Date no action, suit or other proceeding shall be
pending or, to the Trust's knowledge, threatened before any court or
governmental agency in which it is sought to restrain or prohibit, or obtain
damages or other relief in connection with, this Agreement or the transactions
contemplated herein;

         8.3. All consents of other parties and all other consents, orders and
permits of Federal, state and local regulatory authorities deemed necessary by
the Trust to permit consummation, in all material respects, of the transactions
contemplated hereby shall have been obtained, except where failure to obtain any
such consent, order or permit would not involve a risk of a material adverse
effect on the assets or properties of the Acquiring Portfolio or the Acquired
Portfolio, provided that either party hereto may for itself waive any of such
conditions;

         8.4. The Registration Statement shall have become effective under the
1933 Act and no stop orders suspending the effectiveness thereof shall have been
issued and, to the best knowledge of the parties hereto, no investigation or
proceeding for that purpose shall have been instituted or be pending, threatened
or contemplated under the 1933 Act; and

         8.5. The parties shall have received the opinion of Dechert addressed
to the Trust substantially to the effect that, based upon certain facts,
assumptions, and representations, the transaction contemplated by this
<PAGE>
Agreement shall constitute a tax-free reorganization for Federal income tax
purposes. The delivery of such opinion is conditioned upon receipt by Dechert of
representations it shall request of the Trust. Notwithstanding anything herein
to the contrary, the Trust may not waive the condition set forth in this
paragraph 8.5.

9.       BROKERAGE FEES AND EXPENSES

         9.1. The Trust, on behalf of the Acquiring Portfolio and the Acquired
Portfolio, represents and warrants that there are no brokers or finders entitled
to receive any payments in connection with the transactions provided for herein.

         9.2. The expenses relating to the proposed Reorganization will be
shared so that (1) half of such costs are borne by the investment adviser to the
Acquired and Acquiring Portfolios, and (2) half are borne by the Acquired and
Acquiring Portfolios and will be paid by the Acquired Portfolio and Acquiring
Portfolio pro rata based upon the relative net assets of the Acquired Portfolio
and Acquiring Portfolio as of the close of business on the record date for
determining the shareholders of the Acquired Portfolio entitled to vote on the
Reorganization. The costs of the Reorganization shall include, but not be
limited to, costs associated with obtaining any necessary order of exemption
from the 1940 Act, preparation of the Registration Statement, printing and
distributing the Acquiring Portfolio's prospectus and the Acquired Portfolio's
proxy materials, legal fees, accounting fees, securities registration fees, and
expenses of holding shareholders' meetings. Notwithstanding any of the
foregoing, expenses will in any event be paid by the party directly incurring
such expenses if and to the extent that the payment by another person of such
expenses would result in the disqualification of such party as a "regulated
investment company" within the meaning of Section 851 of the Code.

10.      ENTIRE AGREEMENT; SURVIVAL OF WARRANTIES

         10.1. The Trust agrees that it has not made any representation,
warranty or covenant not set forth herein and that this Agreement constitutes
the entire agreement between the parties.

         10.2. The representations, warranties and covenants contained in this
Agreement or in any document delivered pursuant hereto or in connection herewith
shall survive the consummation of the transactions contemplated hereunder. The
covenants to be performed after the Closing shall survive the Closing.

11.      TERMINATION

         This Agreement may be terminated and the transactions contemplated
hereby may be abandoned by either party by (i) mutual agreement of the parties,
or (ii) by either party if the Closing shall not have occurred on or before July
31, 2004, unless such date is extended by mutual agreement of the parties, or
(iii) by either party if the other party shall have materially breached its
obligations under this Agreement or made a material and intentional
misrepresentation herein or in connection herewith. In the event of any such
termination, this Agreement shall become void and there shall be no liability
hereunder on the part of any of the parties including the Trust or its Trustees
or officers, except for any such material breach or intentional
misrepresentation, as to each of which all remedies at law or in equity of the
party adversely affected shall survive.

12.      AMENDMENTS

         This Agreement may be amended, modified or supplemented in such manner
as may be deemed necessary or advisable by the authorized officers of the Trust;
provided, however, that following the meeting of the shareholders of the
Acquired Portfolio called by the Trust pursuant to paragraph 5.2 of this
Agreement, no such amendment may have the effect of changing the provisions for
determining the number of the Class R and Class S Acquiring Portfolio Shares to
be issued to the Acquired Portfolio Shareholders under this Agreement to the
detriment of such shareholders without their further approval.
<PAGE>
13.      NOTICES

         Any notice, report, statement or demand required or permitted by any
provisions of this Agreement shall be in writing and shall be given by
facsimile, personal service or prepaid or certified mail addressed to the Trust,
7337 East Doubletree Ranch Road, Scottsdale, Arizona 85258-2034, attn: Huey P.
Falgout, Jr., with a copy to Dechert LLP, 1775 I Street, N.W., Washington, D.C.
20006, attn: Jeffrey S. Puretz.

14.      HEADINGS; COUNTERPARTS; GOVERNING LAW; ASSIGNMENT; LIMITATION OF
         LIABILITY

         14.1. The Article and paragraph headings contained in this Agreement
are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.

         14.2. This Agreement may be executed in any number of counterparts,
each of which shall be deemed an original.

         14.3. This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware without regard to its principles of
conflicts of laws.

         14.4. This Agreement shall bind and inure to the benefit of the parties
hereto and their respective successors and assigns, but no assignment or
transfer hereof or of any rights or obligations hereunder shall be made by any
party without the written consent of the other party. Nothing herein expressed
or implied is intended or shall be construed to confer upon or give any person,
firm or corporation, other than the parties hereto and their respective
successors and assigns, any rights or remedies under or by reason of this
Agreement.

         14.5. It is expressly agreed that the obligations of the parties
hereunder shall not be binding upon any of the Trustees, shareholders, nominees,
officers, agents, or employees of the Trust personally, but shall bind only the
trust property of such party, as provided in the Declaration of Trust of the
Trust. The execution and delivery by such officers shall not be deemed to have
been made by any of them individually or to impose any liability on any of them
personally, but shall bind only the trust property of such party as provided in
the Declaration of Trust.

IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be
executed by its President or Vice President and its seal to be affixed thereto
and attested by its Secretary or Assistant Secretary.

                               ING VARIABLE PRODUCTS TRUST on behalf of its ING
                               VP GROWTH OPPORTUNITIES VALUE PORTFOLIO

 Attest:
 __________________________    By:______________________________________________
 Secretary
                               Title:___________________________________________

                               ING VARIABLE PRODUCTS TRUST
                               on behalf of its ING VP MIDCAP OPPORTUNITIES
 Attest:
 __________________________    By:______________________________________________

<PAGE>

 Secretary
                               Title:___________________________________________Lucent Technologies - Insightful Proprietary

================================================================================

                        ASSIGNMENT AND LICENSE AGREEMENT

                                     BETWEEN

                            LUCENT TECHNOLOGIES INC.

                                       AND

                             INSIGHTFUL CORPORATION

                        EFFECTIVE AS OF JANUARY 19, 2004

                RELATING TO SOFTWARE PRODUCT (AS DEFINED HEREIN)

================================================================================

<PAGE>
                        ASSIGNMENT AND LICENSE AGREEMENT

                                TABLE OF CONTENTS

Article I. . . . . . . . . . Definitions
Article II . . . . . . . . . Assignment and Licenses Of Software
Article III . . . . . . . . .Patent Licenses
Article IV . . . . . . . . . Payment
Article V . . . . . . . . . .Export Control
Article VI . . . . . . . . . Term And Termination
Article VII. . . . . . . . . Assignability
Article VIII . . . . . . . . Licenses To Related Companies And Improvements
Article IX. . . . . . . . . .Warranty, Disclaimer And Covenants
Article X. . . . . . . . . . General Provisions
Article XI. . . . . . . . . .Dispute Resolution
Article XII. . . . . . . . . Notices And Statements

Appendix A . . . . . . . . . Definitions

                                        i
<PAGE>
                        ASSIGNMENT AND LICENSE AGREEMENT

     THIS  ASSIGNMENT  AND  LICENSE  AGREEMENT (this "Agreement") is made by and
between  Lucent  Technologies Inc., a Delaware corporation ("Lucent"), having an
office  at  600  Mountain  Avenue, Murray Hill, New Jersey 07974, and Insightful
Corporation, a Delaware corporation ("Buyer"), having an office at 1700 Westlake
Avenue  North,  Suite  500,  Seattle,  Washington  98109.  Lucent  and Buyer are
sometimes  referred  to herein individually as a "Party" and collectively as the
"Parties".

     This  Agreement shall be executed by all Parties and shall become effective
on  January  19,  2004  (the  "Effective  Date");

                                    RECITALS

A.     WHEREAS,  Lucent is the owner of certain right, title and interest in and
to  the  Software  Product  as  defined  in  Exhibit  A;  and

B.     WHEREAS,  Lucent wishes to sell and assign, and Buyer wishes to purchase,
all  of  Lucent's  copyright  right,  title  and interest in and to the Software
Product  (as  defined herein) and Buyer wishes to obtain certain patent licenses
related  to  the  Software  Product  as  described  herein.

NOW,  THEREFORE,  in consideration of the mutual agreements and covenants herein
contained  and  intending  to  be  legally  bound  thereby, the Parties agree as
follows:

                                    ARTICLE I
                                   DEFINITIONS

1.01    Unless  defined in the body of this Agreement, as used in this Agreement
any  term in initial capital letters shall have the meaning ascribed in Appendix
A  attached  hereto.

                                   ARTICLE II
                       ASSIGNMENT AND LICENSES OF SOFTWARE

2.01    Assignment  of Software Product. Subject to receipt of the first payment
        -------------------------------
set  forth  in Section 4.01 and to the licenses granted to Lucent, Lucent hereby
irrevocably  transfers  and  assigns  to Buyer all of Lucent's present worldwide
right,  title  and  interest  in  and to (i) the Software Product, including all
copyright,  trade  secret  and  other  intellectual  property rights (other than
patent  rights  which  are  specifically  set  forth  in  Article III) which are
specific  thereto;  and  (ii)  if  any,  the  name  and  mark  "S" to the extent
protectible  as  a  trademark  or  service  mark (the "Mark"), together with all
associated goodwill. The transfer and assignment of the Software Product and the
Mark  shall  be  subject  to  all

<PAGE>
Prior  Lucent  Agreements.  Upon  request  of Buyer, Lucent agrees to execute an
assignment  of  copyright and/or of trademark, which assignment(s) shall reflect
the  terms  and conditions herein. Buyer agrees not to assert any claim or bring
any  suit  or  proceeding  against any third party based on Buyer's intellectual
property  rights  in  or  ownership  of Software Product relating to use by such
third  party  of  any  software,  documentation or other material contributed by
Lucent,  its  Subsidiaries or any of its employees to the R or Omegahat Projects
prior  to  January  1,  2004.

2.02    License  to Assigned Software. In partial consideration for the transfer
        -----------------------------
and  assignment  of  the  Software  Product  by Lucent to Buyer, Buyer grants to
Lucent  a personal, nonexclusive, nontransferable (except as provided in Article
VII),  irrevocable  (except as provided in Article VI), worldwide, fully paid-up
license  to  use, copy, perform or display the Software Product for internal use
and  create,  use, copy, perform or display derivative works (as defined by U.S.
copyright  law)  from  the  Software  Product  for  internal  use.

2.03    Additional  Rights.  In  addition  to the foregoing license to Lucent in
        ------------------
Section  2.02,  it shall not be a breach of this Agreement or a violation of any
intellectual property right of Buyer if Lucent (including its employees, agents,
Subsidiaries  and contractors), without copying any portion of Software Product,
develops  software,  which  is  (i)  similar  to Software Product, (ii) based on
information  or  descriptions that are either (A) available in the public domain
or  (B)  to  which  Lucent  has  rights other than through this Agreement, (iii)
provides similar or identical functionality as Software Product, (iv) written in
the  S  language  and/or  (v)  has  a  similar  or identical application program
interface  as  the  Software Product. Subject to the restriction of Section 2.02
that  the  Software  Product  may  only  be used internally, Lucent shall not be
restricted in any way from licensing, selling, developing or exploiting any such
software.

2.04    Furnishing  of  Software Product. Buyer acknowledges and agrees that (i)
        --------------------------------
it  is  already in possession of the Software Product and (ii) Lucent shall have
no  obligations  to furnish or deliver Software Product or any portions thereof.

                                   ARTICLE III
                                 PATENT LICENSES

3.01    Licensed  Patents. Subject to the receipt of the first payment specified
        -----------------
in  Section  4.01,  Lucent  hereby  grants  to  Buyer a personal, fully paid-up,
worldwide,  non-transferable  (except  as  provided in Article VII), irrevocable
(except  as provided in Article VI), and nonexclusive license under the Licensed
Patents  to make, have made, use, sell, offer to sell, lease and import Licensed
Products.  The licenses in this Section include the right convey to any customer
of  the  Buyer,  with respect to any Licensed Product which is sold or leased by
Buyer  to such customer, rights to use and resell such Licensed Products as sold
or  leased  by  Buyer  (whether  or  not  as part of a larger combination). This
license shall not be construed as a right to convey any rights under any patents
other  than Licensed Patents to customers with respect to any invention which is
directed  to (1) a combination of such Licensed Product (as sold or leased) with
any other product regardless of whether such other product is hardware, software
or  another  Licensed  Product,  (2) a method or process which is other than the
inherent  use  of  such

                                        2
<PAGE>
Licensed  Product  itself  (as  sold  or  leased),  or  (3)  any  other  product
manufactured  (including  associated  testing)  by  or  through  the  use of the
Licensed  Product.

3.02    No  Indirect  Infringement License. Licenses granted herein to Buyer are
        ----------------------------------
not to be construed: (i) as consent by grantor to any act which may be performed
by the grantee, except to the extent impacted by a patent licensed herein to the
grantee  or (ii) to include licenses to contributorily infringe any patent other
than  a  Licensed  Patent  or  induce  infringement  under U.S. law or a foreign
equivalent  thereof.

3.03    Term.  The  patent  licenses  granted  herein  under  any  patent  shall
        ----
continue, unless otherwise terminated in accordance with this Agreement, for the
entire unexpired term of such patent, but if, upon commencement of the Effective
Date,  the  grantor has no rights, or less than full rights, with respect to any
of  its  patents  included within the definitions hereunder, the license granted
herein  under  such  patent  shall  be  for  as much of such term as, and to the
maximum  extent  that,  the  grantor  has  the  right  to  grant.

3.04    No  Sham.  The "have made" rights granted hereunder to a Party shall not
        --------
be exercised in a manner that the exercise of such have made rights is a sham to
sublicense the other Party's patents licensed hereunder to a third party and not
for  bona  fide  business  purposes  of  such  Party.

                                   ARTICLE IV
                                     PAYMENT

4.01  Payments.  In  consideration  for the assignment and licenses hereunder by
      --------
Lucent  to  Buyer,  Buyer  shall pay to Lucent a sum of two million U.S. dollars
(U.S.  $2,000,000.00)  at  the  address  specified  in  Section  4.05.  For  the
convenience  of  the  Parties,  Buyer  has  elected  to  pay such sum in two (2)
installments  as  follows:

------------------------------------------------------------------------
     PAYMENT NUMBER         AMOUNT                  DUE DATE
---------------------  ------------------  -----------------------------
          1            $ 1,500,000.00      within five (5) business days
                                            of the Effective Date hereof
---------------------  ------------------  -----------------------------
          2            $   500,000.00      Within one (1) year of the
                                              Effective Date hereof
------------------------------------------------------------------------

In  addition  to the foregoing, to the extent Lucent or its Subsidiaries has any
payment, royalty or other monetary obligations to any third party as a result of
the  grant  of  licenses  under  Licensed Patents in Article III, Buyer shall be
responsible for reimbursing Lucent or its Subsidiaries for such payment, royalty
or  other  monetary  obligations.

4.02    No  Refund.  No refund, credit or other adjustment of payments hereunder
        ----------
shall  be made by Lucent. Rights conferred by Section 4.01 shall not be affected
by  any statement appearing on any check or other document, except to the extent
that  any  such  right is expressly waived or surrendered by a Party having such
right  and  signing  such  statement.

                                        3
<PAGE>
4.03    Payment  in  U.S. Dollars. All payments under Section 4.01 shall be made
        -------------------------
in United States dollars to Lucent at the address specified in Section 4.05. Any
conversion  to  United  States  dollars shall be at the prevailing rate for bank
cable  transfers as quoted for the last day of such semiannual period by leading
United  States  banks  in  New York City dealing in the foreign exchange market.

4.04    Overdue  Payments. Overdue payments hereunder shall be subject to a late
        -----------------
payment charge calculated at an annual rate of three percentage points (3%) over
the  prime rate or successive prime rates (as posted in New York City by leading
United  States  banks)  during delinquency. If the amount of such charge exceeds
the  maximum  permitted  by  law,  such charge shall be reduced to such maximum.

4.05    Payment  Address.  Payments by Buyer shall be made to Lucent at Lucent's
        ----------------
account.  Payments  may  be  made  via  wire transfers to the following address:
Lucent  Technologies  Inc.,  Account  # 323861415, Chase Manhattan Bank, 1 Chase
Plaza,  New  York,  NY  10081,  Swift  Code  CHASUS33,  ABA  Code  021000021.
Alternatively,  payments  made  by  check  should  be  made  payable  to  Lucent
Technologies  Inc.  and sent to: Lucent Technologies Inc., Bank of America, 6000
Feldwood  Road,  College  Park, GA 30349, Attn. Lock-Box 277078. Changes in such
address  or  account  may  be  specified  by  written  notice.

                                    ARTICLE V
                                 EXPORT CONTROL

5.01  (a)     The  Parties  acknowledge  that  any  information  and  software
(including,  but  not  limited  to,  services  and training) provided under this
Agreement  are  subject  to  U.S.  export  laws  and  regulations and any use or
transfer  of  such  information  and  software  must  be  authorized under those
regulations.  Each  Party  hereby  assures  the other that it will not without a
license  or  license exception authorized by the Bureau of Export Administration
of  the  U.S.  Department  of Commerce, Washington, D.C. 20230, United States of
America,  if  required:

     (i)  export  or release the information or software (including source code)
          obtained  pursuant  to  this Agreement to a national of Country Groups
          D:1 or E:2 (15 C.F.R. Part 740, Supp. 1), Iran, Iraq, Sudan, or Syria;

     (ii) export  to  Country  Groups  D:1  or  E:2, or to Iran, Iraq, Sudan, or
          Syria,  the  direct  product (including processes and services) of the
          information  or  software;  or

    (iii) if  the  direct  product of the information is a complete plant or any
          major component of a plant, export to Country Groups D:1 or E:2, or to
          Iran,  Iraq, Sudan, or Syria, the direct product of the plant or major
          component.

     (b)  This  assurance  will  be  honored  even after any termination of this
          Agreement.

                                        4
<PAGE>
                                   ARTICLE VI
                              TERM AND TERMINATION

6.01    Term.  This  Agreement  shall be effective during the term commencing on
        ----
the  Effective Date hereof and shall continue, subject to the term of the patent
licenses  granted  in  Article  III,  unless  terminated (i) by mutual agreement
between the Parties; or (ii) pursuant to this Article VI. The Parties agree that
any  breach  other  than  as  specified in Section 6.02 shall not be a basis for
termination  of  any rights or licenses granted hereunder but rather such breach
shall  be  resolved  pursuant  to  Article  XI.

6.02    Failure  to  Pay. If Buyer fails to make a payment called for in Article
        ----------------
IV,  to  the  extent that any such failure is not attributable to any failure on
the  part  of the Seller to perform any of its obligations under this Agreement,
the  Seller  upon its election and in addition to any other remedies that it may
have, may at any time terminate the licenses (or any part thereof) granted under
this  Agreement  by  not  less  than two (2) months written notice to the Buyer,
unless  within  the period of such notice such payment has been made or Buyer is
contesting  in  good  faith  its  obligation  to  make  such  payment.

6.03    Survival.  The  rights  and  obligations  of the Parties which, by their
        --------
nature,  would  continue  beyond termination of this Agreement shall survive and
continue  after  any termination of this Agreement. For example, the obligations
of  the Parties under Sections 5.01 and 9.02, licenses to customers with respect
to  products  sold  by  a Party prior to any such termination, and in connection
with  any  termination  under Section 6.02 licenses granted to the non-breaching
Party  hereunder  shall  survive  and  continue.

                                   ARTICLE VII
                                  ASSIGNABILITY

7.01    No Assignability. The Parties hereto have entered into this Agreement in
        ----------------
contemplation  of  personal  performance, each by the other, and intend that the
licenses  and  rights  granted  hereunder to a Party not be extended to entities
other  than  such Party's Subsidiaries without the other Party's express written
consent.

7.02    Successors.  Notwithstanding  Section  7.01,  all  of  a Party's rights,
        ----------
title,  obligations  and  interest in this Agreement and any licenses and rights
granted  to  it hereunder may be assigned to any direct or indirect successor to
all  or  a  portion  of  the  business  of  the Party or its Subsidiaries, which
successor  shall thereafter be deemed substituted as the Party hereto, effective
upon  such  assignment.

                                  ARTICLE VIII
                 LICENSES TO RELATED COMPANIES AND IMPROVEMENTS

8.01    Licenses  to  Subsidiaries. The grant of each license hereunder includes
        --------------------------
the  right  to  grant  sublicenses within the scope of such license to a Party's
Subsidiaries  for  so  long  as  they  remain  its

                                        5
<PAGE>
Subsidiaries.  Any  and  all  licenses  or  sublicenses  granted to Subsidiaries
pursuant to this Agreement may be made effective retroactively, but not prior to
the  Effective Date hereof, nor prior to the sublicensee's becoming a Subsidiary
of  such  Party.

8.02    No  Other  Licenses.  Unless  otherwise  specifically  expressed in this
        -------------------
Agreement, no license to, or right of a Party, under any of such Party's patent,
copyright, trademark, trade secret, or any other intellectual property right, is
either  granted  or  implied.

8.03    Improvements. No rights are granted to a Party under any improvements or
        ------------
derivative works (as defined by U.S. copyright law) of the information disclosed
in  Software  Product or any patent licensed hereunder to the extent made by the
other  Party  after  the  Effective  Date.

                                   ARTICLE IX
                       WARRANTY, DISCLAIMER AND COVENANTS

9.01  (a)     Lucent  represents  and  warrants that it is the sole owner of all
copyright  rights, title, and interest in and to the Software Product worldwide,
and  that it has the right, without violation of any law or third party interest
or agreement, to enter into this Agreement and to make and grant the assignments
and  licenses  herein  without  any  liens,  claims  or  encumbrances.

     (b)     Lucent warrants that, to the knowledge of its Intellectual Property
Business (a business unit of Lucent which in the ordinary course of its business
should  be apprised of infringements or misappropriations of Lucent intellectual
property and of any licenses granted under Lucent intellectual property), it has
received  no  written claim or written notice from any third party alleging that
any  of  the  Software  Product  in  their  current  form,  or any uses thereof,
constitute  infringements  or  misappropriations of any third-party intellectual
properties  or  rights.

     (c)     Lucent  represents  that,  to  the  knowledge  of  its Intellectual
Property  Business Lucent is not a party to a written license between Lucent and
any  of  its  Subsidiaries  with  respect  to  the  Software  Product.

     (d)     EXCEPT  AS  OTHERWISE  SET  FORTH IN THIS ARTICLE IX, THE SOFTWARE,
PATENTS,  TRADEMARKS  OR  OTHER  INFORMATION  ASSIGNED  OR  LICENSED  UNDER THIS
AGREEMENT  IS  ASSIGNED  OR LICENSED "AS IS" WITH ALL FAULTS, LATENT AND PATENT,
AND  WITHOUT  ANY  WARRANTY  OF  ANY  TYPE.  LUCENT AND ITS SUBSIDIARIES MAKE NO
REPRESENTATIONS  OR WARRANTIES, EXPRESSED OR IMPLIED. BY WAY OF EXAMPLE, BUT NOT
OF  LIMITATION,  LUCENT  AND  ITS  SUBSIDIARIES  MAKE  NO  REPRESENTATIONS  OF
MERCHANTABILITY  OR  FITNESS  FOR  A  PARTICULAR  PURPOSE OR THAT THE USE OF THE
SOFTWARE,  PATENTS, TRADEMARKS OR OTHER INFORMATION WILL NOT INFRINGE ANY PATENT
OR  OTHER  INTELLECTUAL  PROPERTY  RIGHT OF ANY THIRD PARTY, AND IT SHALL BE THE
SOLE  RESPONSIBILITY  OF  BUYER

                                        6
<PAGE>
TO  MAKE  SUCH  DETERMINATION AS IS NECESSARY WITH RESPECT TO THE ACQUISITION OF
LICENSES  UNDER  PATENTS OR OTHER INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES.

     (e)     LIMITATION  OF REMEDIES; DISCLAIMER. THE ENTIRE LIABILITY OF LUCENT
             -----------------------------------
FOR BREACH OF THE WARRANTY OBLIGATIONS IN THIS SECTION 9.01 SHALL NOT EXCEED THE
AMOUNT  PAID  BY  BUYER  TO  LUCENT  HEREUNDER (NOT TO EXCEED TWO MILLION UNITED
STATES  DOLLARS  (U.S.  $2,000,000.00)).  EXCEPT  AS OTHERWISE DESCRIBED HEREIN,
LUCENT  AND  ITS SUBSIDIARIES SHALL NOT BE HELD TO ANY LIABILITY WITH RESPECT TO
ANY  PATENT  INFRINGEMENT OR ANY OTHER CLAIM MADE BY BUYER OR ANY THIRD PARTY ON
ACCOUNT  OF,  OR ARISING FROM THE USE OF, SOFTWARE, PATENTS, TRADEMARKS OR OTHER
INFORMATION  ASSIGNED  OR  LICENSED  HEREUNDER.

9.02  Lucent  and  Buyer  agree:

     (a)     that Buyer will not, without Lucent's express written permission or
as  provided  herein  or in the Purchase Agreement, or as otherwise agreed to in
writing,  (i)  use  in  advertising,  publicity,  or  otherwise  any trade name,
trademark, trade device, service mark, symbol or any other identification or any
abbreviation,  contraction  or simulation thereof owned or used by Lucent or any
of its Subsidiaries, or (ii) represent, directly or indirectly, that any product
or  service  produced  in  whole  or in part with the use of any of the Software
Product  or  patents licensed hereunder is a product or service of Lucent or any
of  its  Subsidiaries (other than truthful, factual and non-prominent statements
relating  to  the  history  of  the  development  of  the Software Product); and

     (b)     that  except as otherwise expressly provided for in this Agreement,
Lucent  will  hold  in  confidence  for Buyer all parts of the Software Product.
Lucent  further  agrees that Software Product shall remain the property of Buyer
and  that  Lucent  shall  not  make  any disclosure of such to anyone, except to
employees, contractors and agents of Lucent to whom such disclosure is necessary
to  the  use  for  which  rights  are  granted  hereunder.

     (c)     the  restrictions  under this Section 9.02 on the use or disclosure
of  such  information  shall  not  apply  to  such  information:

     (i)  which  is  publicly  available  as  of  the  Effective  Date;

     (ii) which  is  independently  developed  by Lucent or is lawfully received
          free of restriction from another source having the right to so furnish
          such  information;  or

    (iii) after  it  has  become  generally  available to the public by acts not
          attributable  to  Lucent  or  its employees, agents or contractors; or

     (iv) which  Buyer  agrees  in  writing  is  free  of  such restrictions; or

                                        7
<PAGE>
     (v)  which is inevitably disclosed by licensed use of Software Product or a
          Licensed  Product;  or

     (vi) which  is  requested  pursuant  to a judicial or governmental request,
          requirement  or  order  under law, provided that Lucent provides buyer
          with  sufficient  prior  notice  in  order  to  contest  such request,
          requirement  or  order  or  seek  protective  measures.

9.03  No  Party  or  its  Subsidiaries will under any circumstance, whether as a
result  of  breach  of  contract, breach of warranty, delay, negligence, tort or
otherwise,  be  liable  to  the  other  Party  or  to  any  third  party for any
consequential, incidental, special, punitive or exemplary damages and/or loss of
profits,  savings  or revenues of the other Party or any third party arising out
of  this  Agreement, whether or not the applicable Party or its Subsidiaries has
been  notified  of  the  possibility  or  likelihood  of  such  damages.

9.04  Buyer  agrees  to  indemnify and save Lucent and its Subsidiaries harmless
from  any  claims  or  demand  for personal injury or property damage (including
reasonable expense of litigation and settlement of such claims) by third persons
to the extent that such claims arise out of or in connection with the furnishing
or  use  of  any  information  or  software  provided  hereunder.

9.05  Lucent  agrees  to  indemnify and save Buyer and its Subsidiaries harmless
from  any  claims  or  demand  for personal injury or property damage (including
reasonable expense of litigation and settlement of such claims) by third persons
to  the  extent that such claims arise out of or in connection with the licenses
provided  to  Lucent  hereunder.

9.06  The Party indemnified under section 9.04 or 9.05 shall promptly notify the
indemnifying  Party  of any third party claims and afford the indemnifying Party
the  opportunity to control the defense and settlement thereof. The indemnifying
Party  shall  not  be liable for admissions made or amounts paid or agreed to be
paid  in  settlement  without  the  consent  of  the  indemnifying  Party.

                                    ARTICLE X
                               GENERAL PROVISIONS

10.01 Consideration. The consideration, the sufficiency of which is acknowledged
      -------------
by  the Parties, for the transfers, assignments and grant of rights and licenses
under  this  Agreement  is  provided  hereunder.

10.02  Agreement  Prevails.  This  Agreement  shall  prevail in the event of any
       -------------------
conflicting terms or legends, which may appear on documents, Software Product or
patents  assigned  or  licensed  hereunder.

10.03  Relationship  Between Parties. Neither Party to this Agreement shall have
       -----------------------------
the power to bind the other by any guarantee or representation that it may give,
or  to  incur  any debts or liabilities in the name of or on behalf of the other
Party.  The  Parties  acknowledge  and  agree  that  nothing  contained  in this

                                        8
<PAGE>
Agreement  shall  be  deemed  or  construed  to constitute or create between the
Parties hereto a partnership, association, joint venture or other agency.

10.04  Entire  Agreement.  This  Agreement  sets  forth the entire agreement and
       -----------------
understanding  between  the  Parties  as to the disposition, rights and licenses
with  respect  to  the Software Product and merges all prior discussions between
them,  and  none  of  the Parties shall be bound by any conditions, definitions,
warranties,  modifications,  understandings  or  representations with respect to
such  subject  matter  other  than  as expressly provided herein, or as duly set
forth  on  or subsequent to the Effective Date hereof in writing and signed by a
proper and duly authorized representative of the Party to be bound thereby.

10.05  Agreement  Confidentiality.  The  terms,  but  not the existence, of this
       --------------------------
Agreement  shall  be  treated as confidential information by the Parties, and no
Party  shall  disclose  such  terms to any third party without the prior written
consent of the other Party; provided, however, that each Party may (i) represent
to  third  parties  that  such Party is licensed for the products and patents as
provided  by  this  Agreement; and (ii) disclose this Agreement and its terms to
potential  acquirers  of,  investors  in  or  lenders  to such Party (and to the
representatives  of  the  parties  in  such  a  transaction),  or in disclosures
reasonably necessary in connection with the divestiture of all or any portion of
a  Party's respective businesses, provided such disclosure is made pursuant to a
written confidentiality agreement binding upon such potential acquirer, investor
or  lender  which  contains  confidentiality  obligations  which  are  no  less
protective  than  at least the same degree of care the disclosing Party normally
exercises  to  protect  its  own proprietary information of a similar nature. In
addition,  this  Section 10.05 shall not prevent a Party from making disclosures
reasonably required by law or as required by a stock exchange.

10.06  Headings. Section and subsection headings contained in this Agreement are
       --------
inserted  for convenience of reference only, shall not be deemed to be a part of
this  Agreement  for  any purpose, and shall not in any way define or affect the
meaning,  construction  or  scope  of  any  of  the  provisions  hereof.

10.07  Further  Actions.  Each  Party agrees to execute, acknowledge and deliver
       ----------------
such  further instruments, and to do all such other acts, as may be necessary or
appropriate  in  order  to  carry out the purposes and intent of this Agreement.

10.08  Governing Law. The Parties agree that this Agreement shall be governed by
       -------------
and  construed  and  interpreted in accordance with the laws of the State of New
York,  excluding  the  choice  of  law  rules  thereof.

10.09 Force Majeure. A Party shall not lose any rights hereunder or be liable to
      -------------
the  other  Party  for damages or losses on account of failure of performance by
the  defaulting  Party  if  the failure is occasioned by government action, war,
fire,  explosion,  flood,  strike,  lockout, embargo, act of God, or other cause
beyond  the  reasonable control of the defaulting Party, provided that the Party
claiming  force  majeure has exerted commercially reasonable efforts to avoid or
remedy  such  force  majeure.

10.10  Waiver.  Except as specifically provided for herein, the waiver from time
       ------
to  time  by  a  Party  of  any of their rights or their failure to exercise any
remedy  shall  not operate or be construed as a

                                        9
<PAGE>
continuing waiver of the same or of any other of such Party's rights or remedies
provided  in  this  Agreement.

10.11  Severability. If any term, covenant or condition of this Agreement or the
       ------------
application  thereof to any Party or circumstances shall, to any extent, be held
to  be  invalid  or  unenforceable, then the remainder of this Agreement, or the
application  of  such  term,  covenant  or condition to parties or circumstances
other  than  those as to which it is held invalid or unenforceable, shall not be
affected thereby and each term, covenant or condition of this Agreement shall be
valid and be enforced to the fullest extent permitted by law.

10.12  No  Obligation.  Except  as  otherwise agreed in this Agreement or in the
       --------------
Settlement  Agreement, the Parties shall have no right or interest whatsoever in
any  product  of the other Party, whether such product is conceived or developed
by  the other Party, during or after the course of performance of this Agreement
or  the  Settlement  Agreement.  Nothing in this Agreement shall be construed to
obligate any Party to a specified level of effort in its promotion and marketing
of  any  product.

10.13 Execution in Counterparts. This Agreement may be executed in any number of
      -------------------------
counterparts,  each  of  which  shall be deemed an original (including facsimile
copies), but all of which together shall constitute one and the same instrument.

                                   ARTICLE XI
                               DISPUTE RESOLUTION

11.01  Notice  of  default  or breach shall be tendered in writing and the Party
receiving  such notice shall have sixty (60) days from receipt of such notice to
cure the default or breach before invoking the balance of this section 11.01. If
after  such  period  the  default  or breach remains uncured, the Parties agree:

     (a) If a dispute arises out of or relates to this Agreement, or the breach,
termination  or  validity  thereof, the Parties agree to submit the dispute to a
sole  mediator selected by the Parties or, at any time at the option of a Party,
to  mediation  by  the  American  Arbitration  Association  ("AAA"). If not thus
resolved,  it  shall  be  referred  to a sole arbitrator selected by the Parties
within  thirty  (30) days of the mediation, or in the absence of such selection,
to AAA arbitration which shall be governed by the United States Arbitration Act.

     (b)  Any  award  made (i) shall be a bare award limited to a holding for or
against  a  Party  and  affording  such  remedy as is deemed equitable, just and
within  the  scope of the Agreement; (ii) shall be without findings as to issues
(including  but  not  limited  to  patent  validity  and/or  infringement)  or a
statement  of  the  reasoning on which the award rests; (iii) may in appropriate
circumstances (other than patent disputes) include injunctive relief; (iv) shall
be made within four (4) months of the appointment of the arbitrator; and (v) may
be  entered  in  any  court.

                                       10
<PAGE>
     (c)  The  requirement  for  mediation and arbitration shall not be deemed a
waiver  of  any  right of termination under this Agreement and the arbitrator is
not empowered to act or make any award other than based solely on the rights and
obligations  of  the  Parties  prior  to  any  such  termination.

     (d)  The  arbitrator  shall  determine  issues of arbitrability but may not
limit,  expand  or  otherwise  modify  the  terms  of  the  Agreement.

     (e)  The  place  of  mediation  and  arbitration  shall  be  New York City.

     (f)  Each  Party  shall  bear  its  own  expenses  but those related to the
compensation and expenses of the mediator and arbitrator shall be borne equally.

     (g)  A  request  by  a  Party  to a court for interim measures shall not be
deemed  a  waiver  of  the  obligation  to  mediate  and  arbitrate.

     (h)  The  arbitrator  shall  not  have  authority  to  award  punitive,
consequential,  incidental,  special,  exemplary  or  other damages in excess of
compensatory  damages  and  each  Party  irrevocably  waives  any claim thereto.

     (i)  Except  as  reasonably  required  by  law  or  as  required by a stock
exchange,  the  Parties,  their  representatives,  other  participants  and  the
mediator  and  arbitrator  shall  hold  the  existence,  content  and  result of
mediation  and  arbitration  in  confidence.

                                   ARTICLE XII
                             NOTICES AND STATEMENTS

12.01  Until  further  notice  in  writing,  any  notice  or other communication
hereunder  shall  be  deemed  to  be sufficiently given to the addressee and any
delivery  hereunder deemed made when sent by certified mail to the addresses set
out  below.

For Lucent:     Contract  Administrator
                Intellectual  Property  Business
                Lucent  Technologies  Inc.
                14645  N.W.  77th  Avenue,  Suite  105
                Miami  Lakes,  Florida  33014

With Copy to:   Lucent  Technologies  Inc.
                Intellectual  Property  Law  Department
                600  Mountain  Avenue
                Murray  Hill,  New  Jersey  07974

                                       11
<PAGE>

For Buyer:      General  Counsel
                Insightful  Corporation
                1700  Westlake  Avenue  North
                Suite  500
                Seattle,  Washington  98109

With Copy to    President
                Insightful  Corporation
                1700  Westlake  Avenue  North
                Suite  500
                Seattle,  Washington  98109

                                       12
<PAGE>
IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be executed
by  its  duly  authorized  representative on the respective dates entered below.

LUCENT TECHNOLOGIES INC.

By:                      /s/ Bernard Zucker
   -----------------------------------------------------------------
                             B. Zucker
                    Managing Corporate Counsel

Date:                         1/16/04
     ---------------------------------------------------------------

INSIGHTFUL CORPORATION

By:                     /s/ Jeffrey Coombs
   -----------------------------------------------------------------
                             J. Coombs
                         President and CEO

Date:                         1/19/04
     ---------------------------------------------------------------

               THIS AGREEMENT DOES NOT BIND OR OBLIGATE ANY PARTY
                IN ANY MANNER UNLESS DULY EXECUTED BY AUTHORIZED
                         REPRESENTATIVES OF ALL PARTIES

                                       13
<PAGE>
                                   APPENDIX A
                                   DEFINITIONS

"Licensed  Patents"  means  every  patent anywhere in the world issued as of the
-------------------
Effective  Date  or  which  issues from an application having an effective first
filing  date prior to the Effective Date under which Lucent or its Subsidiaries,
as  of  the  Effective  Date,  has  the  right to grant (with or without thereby
generating  any payment or other monetary obligation to any third party, but not
including  instances  wherein  a  non-monetary  obligation  by  Lucent  or  its
Subsidiaries is generated, other than reporting and auditing obligations related
to  monetary  obligations)  any  licenses  of  the type herein granted by Lucent
(whether  or not royalty-bearing), but only to the extent of such right, and but
for  the  licenses  granted  herein  would  be infringed by the execution of the
inherent  functionality  of  Software  Product.

"Licensed Products" means any product incorporating portions of Software Product
-------------------
or  that  is  a  derivative  work (as defined by U.S. copyright law) of Software
Product.

"Prior  Lucent  Agreements"  means  all prior written agreements (or replacement
---------------------------
agreements  thereof)  between  (on  the  one  hand)  Lucent,  its  predecessors
(including AT&T Corp. and AT&T's Subsidiaries) and/or Lucent's Subsidiaries, and
(on  the  other  hand)  one or more third parties (other than Lucent affiliates)
that  have  an  effective  date  prior  to the Effective Date of this Agreement.

"SLA"  means  the  Software License Agreement, effective as of February 8, 1996,
-----
relating  to  Lucent's  S Software, as amended by subsequent agreements, between
Lucent  Technologies  Inc.  and  Statistical  Sciences,  Inc.

"Software Product" shall have same meaning as in the SLA.
-----------------

"Subsidiary"  of  a  company  means a corporation or other legal entity (i) more
------------
than  fifty  percent  (50%) of whose shares or other securities entitled to vote
for  election  of  directors  (or  other managing authority) is now or hereafter
controlled by such company either directly or indirectly; or (ii) which does not
have outstanding shares or securities but more than fifty percent (50%) of whose
ownership  interest  representing  the right to manage such corporation or other
legal  entity  is  now  or hereafter owned and controlled by such company either
directly  or indirectly; but any such corporation or other legal entity shall be
deemed  to  be  an  Subsidiary  of  such company only as long as such control or
ownership  and  control  exists.

                                       14
<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}]]